52
Publications
2.8K
Citations
29
H-Index
1996
Active since
Meirong Xu is an author at Oregon State University specializing in medicine, pharmacology, and engineering.
Top concepts
MedicinePharmacologyEngineeringMicrobiologyPlant PathologyGeneticsPathologyToxicologyBiochemistryBiology
Publications per year
1996–2025
52
52
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance
Ping Chen, Nathan V. Lee, Wenyue Hu et al. · Molecular Cancer Therapeutics · 2016 · 414 citations
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 172 citations
Meirong Xu, Anne Bailey, Judith F. Hernaez et al. · Carcinogenesis · 1996 · 140 citations · Full text
Rows per page
1–5 of 52